Arcadia Biosciences Inc. (RKDA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Arcadia Biosciences Inc.

    NASDAQ: RKDA · Real-Time Price · USD
    3.35
    -0.16 (-4.56%)
    At close: Sep 26, 2025, 1:15 PM

    Arcadia Biosciences Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 5.04M 5.33M 9.96M 6.78M
    Cost of Revenue
    		 2.96M 3.3M 9.8M 8.71M
    Gross Profit
    		 2.08M 2.03M 154K -1.93M
    Operating Income
    		 -3.65M -13.87M -19.4M -35.53M
    Interest Income
    		 782K 695K 289K n/a
    Pretax Income
    		 -4.31M -13.16M -15.6M -16.13M
    Net Income
    		 -7.04M -13.98M -15.61M -16.13M
    Selling & General & Admin
    		 9.64M 14.51M 18.05M 22.94M
    Research & Development
    		 53K 1.39M 1.51M 3.89M
    Other Expenses
    		 -3.96M n/a 33K n/a
    Operating Expenses
    		 5.73M 15.89M 19.56M 26.83M
    Interest Expense
    		 n/a n/a n/a 20K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 12.66M 19.2M 29.36M 35.53M
    Income Tax Expense
    		 8K 8K 14K 2K
    Shares Outstanding (Basic)
    		 1.36M 1.24M 599.39K 532.01K
    Shares Outstanding (Diluted)
    		 1.36M 1.24M 599.39K 532.01K
    EPS (Basic)
    		 -5.16 -11.3 -26.05 -30.33
    EPS (Diluted)
    		 -5.16 -11.3 -26.05 -30.33
    EBITDA
    		 -7.5M -13.58M -13.65M -23.27M
    EBIT
    		 -7.61M -13.16M -15.23M -28.75M
    Depreciation & Amortization
    		 n/a 287K 1.36M 1.04M

    Add to Watchlist